Shine N R, Xuan J A, Koretsky A P, Weiner M W
Magn Reson Med. 1987 Mar;4(3):244-51. doi: 10.1002/mrm.1910040305.
A technique to determine absolute metabolite concentrations of the kidney in vivo using 31P NMR is described. The technique is based on the use of methylphosphonic acid (MPA), which gives rise to a well-resolved peak upfield from in vivo phosphorous metabolite resonances, as an "internal standard." The method involves acquisition of a fully relaxed kidney spectrum with an implanted coil followed by intravenous infusion of MPA (4 ml of 150 mM) for a period of 30 min. The animal is then sacrificed to insure a steady state level of renal MPA and another spectrum is obtained. From these two spectra the ratio of intensities of MPA to beta-ATP was derived. In the method used here, no significant contribution from tissues outside the kidney was observed. In addition, a relatively homogeneous distribution of MPA throughout the kidney was achieved. The amount of MPA per gram wet weight of kidney was also obtained through NMR methods by placing the excised organ in a phosphate-calibrated solenoidal coil. The calibration spectra along with the ratio of intensities for MPA/beta-ATP were used to calculate the number of micromoles of ATP per gram wet weight of kidney. Infusion of a higher concentration of MPA (1.25 M) produced a visible MPA resonance in other organs besides the kidney. Thus, MPA could be useful in determining phosphate metabolite concentrations in other tissues.
描述了一种使用31P NMR在体内测定肾脏绝对代谢物浓度的技术。该技术基于使用甲基膦酸(MPA)作为“内标”,MPA在体内磷代谢物共振的高场产生一个分辨率良好的峰。该方法包括用植入线圈采集完全弛豫的肾脏光谱,然后静脉输注MPA(4 ml 150 mM)30分钟。然后处死动物以确保肾脏MPA达到稳态水平,并获得另一个光谱。从这两个光谱中得出MPA与β-ATP的强度比。在此处使用的方法中,未观察到肾脏外组织的显著贡献。此外,MPA在整个肾脏中实现了相对均匀的分布。通过将切除的器官置于磷酸盐校准的螺线管线圈中,也通过NMR方法获得了每克肾脏湿重的MPA量。校准光谱以及MPA/β-ATP的强度比用于计算每克肾脏湿重的ATP微摩尔数。输注更高浓度的MPA(1.25 M)在肾脏以外的其他器官中产生了可见的MPA共振。因此,MPA可用于测定其他组织中的磷酸盐代谢物浓度。